MARKET

ZTS

ZTS

Zoetis Inc
NYSE
179.84
-0.92
-0.51%
After Hours: 179.84 0 0.00% 18:24 07/26 EDT
OPEN
182.26
PREV CLOSE
180.76
HIGH
183.85
LOW
179.26
VOLUME
2.44M
TURNOVER
0
52 WEEK HIGH
201.92
52 WEEK LOW
144.46
MARKET CAP
82.06B
P/E (TTM)
34.66
1D
5D
1M
3M
1Y
5Y
1D
Zoetis (ZTS) Stock Drops Despite Market Gains: Important Facts to Note
NASDAQ · 4h ago
Zoetis Initiated at Buy by BTIG
Dow Jones · 1d ago
Zoetis Price Target Announced at $220.00/Share by BTIG
Dow Jones · 1d ago
Deep Dive Into Zoetis Stock: Analyst Perspectives (4 Ratings)
Zoetis sells anti-infectives, vaccines, and other health products for animals. The company has an average 12-month price target of $205.25. Zoetis has a positive revenue growth rate of 9.5% over the past three months. The firm has the largest market share in the animal health products industry. 4 analysts have shared their insights on Zoet is in the last three months, with the average price target decreasing by 4.98%.
Benzinga · 1d ago
BTIG Initiates Coverage On Zoetis with Buy Rating, Announces Price Target of $220
Benzinga · 1d ago
Andvari Associates Q2 2024 Letter
For the second quarter of 2024, Andvari was up 7.7% net of fees while the SPDR S&P 500 ETF was up 15.2%. Andvari sold out of two holdings, the largest of which is Mesa. Andvari expects better performance for many of its holdings over the coming years.
Seeking Alpha · 2d ago
Zoetis Earnings Preview: What to Expect
Zoetis Inc. Is scheduled to release its fiscal 2024 Q2 earnings results on Tuesday, Aug. 6. The company is the leading animal healthcare company focusing on livestock and companion animals. Over the past 52 weeks, Zoetis stock has declined 2.3%. The company's shares rose 5.5% in May.
Barchart · 2d ago
Buy Rating Affirmed for Zoetis Amidst Favorable Market Dynamics and Strong Growth Potential
TipRanks · 3d ago
More
About ZTS
Zoetis Inc. is an animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. It has a diversified business, commercializing products across eight core species: dogs, cats and horses (companion animals) and cattle, swine, poultry, fish and sheep (livestock); and within seven major product categories: parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics and medicated feed additives. The Company operates through two segments: the United States and International. Within each of these segments, it offers a diversified product portfolio for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America, and its products are sold in more than 100 countries.

Webull offers Zoetis Inc stock information, including NYSE: ZTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZTS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZTS stock methods without spending real money on the virtual paper trading platform.